Neumora Therapeutics NMRA
NASDAQ NMRA
$0.47 +0.01 (+1.37%)
At close: Nov 11, 2026 · 4:00 PM EST

Neumora Therapeutics (NMRA) Common Stock Issued (2022 - 2025)

Updated

Analysis

Neumora Therapeutics (NMRA) Common Stock Issued (2022 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 743.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 247.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 87.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Neumora Therapeutics 88.31 Mn -529.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 216,000.00
Jun 30, 2025 59,000.00
Dec 31, 2024 1.65 Mn
Sep 30, 2024 1.76 Mn
Jun 30, 2024 2.65 Mn
Mar 31, 2024 1.85 Mn
Dec 31, 2023 339,000.00
Sep 30, 2023 234.89 Mn
Jun 30, 2023 404,000.00
Mar 31, 2023 602,000.00
Dec 31, 2022 1.66 Mn
API Access

Neumora Therapeutics Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=NMRA&period=max&api_key=YOUR_API_KEY